Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Depreciation & Amortization (CF) (2017 - 2025)

Selectis Health's Depreciation & Amortization (CF) history spans 14 years, with the latest figure at $362742.0 for Q2 2025.

  • For Q2 2025, Depreciation & Amortization (CF) fell 11.42% year-over-year to $362742.0; the TTM value through Sep 2025 reached $1.1 million, down 33.55%, while the annual FY2024 figure was $1.6 million, 5.78% down from the prior year.
  • Depreciation & Amortization (CF) for Q2 2025 was $362742.0 at Selectis Health, roughly flat from $363020.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $453608.0 in Q3 2022 and bottomed at $357868.0 in Q3 2023.
  • The 5-year median for Depreciation & Amortization (CF) is $432883.5 (2021), against an average of $416006.7.
  • The largest annual shift saw Depreciation & Amortization (CF) rose 18.21% in 2021 before it fell 21.11% in 2023.
  • A 5-year view of Depreciation & Amortization (CF) shows it stood at $447070.0 in 2021, then decreased by 0.64% to $444195.0 in 2022, then fell by 3.03% to $430754.0 in 2023, then dropped by 15.79% to $362723.0 in 2024, then rose by 0.01% to $362742.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Depreciation & Amortization (CF) are $362742.0 (Q2 2025), $363020.0 (Q1 2025), and $362723.0 (Q4 2024).